2,4-dioxoimidazolidine compounds and compositions, and processes for administering same
AssigneeCassella Aktiengesellschaft
InventorsGerhard Zoller, Wolfgang Konig, Jochen Knolle, Melitta Just, Bernd Jablonka
Life of this patent
Estimating the term…
Abstract
The present invention relates to 2,4-dioxoimidazolidine compounds of the formula I ##STR1## a process for their preparation and their use as inhibitors of platelet aggregation, metastasis of carcinoma cells and osteoclast binding to the bone surfaces.
Claims5
Compound of the formula I ##STR18## in which Y denotes --(CH.sub.2).sub.m --CO--, where m represents an integer from 1 to 4, or ##STR19## R.sup.1 denotes --(CH.sub.2).sub.n --NH--X, where n represents an integer from 1 to 6, --(CH.sub.2).sub.p --C.sub.6 H.sub.4 --NH--X, --(CH.sub.2).sub.p --C.sub.6 H.sub.4 --C(.dbd.NH)--NH.sub.2 or --(CH.sub.2).sub.p --C.sub.6 H.sub.4 --CH.sub.2 --NH--X, where p in each case represents 1 or 2, or where ##STR20## is replaced by ##STR21## X.sup.1 denotes --NHX, --CH.sub.2 NHX or --C(=NH)--NH.sub.2 ;
- X denotes hydrogen, (C.sub.1 -C.sub.6)-alkyl or a radical of the formula II ##STR22## where R' and R" independently of one another represent hydrogen or (C.sub.1 -C.sub.6)-alkyl;
- R.sup.2 denotes hydrogen or (C.sub.1 -C.sub.6)-alkyl;
- R.sup.3 denotes hydrogen or phenyl;
- R.sup.4 denotes --COOR.sup.5, --CO--N (CH.sub.3)--R.sup.5 or --CO--NH--R.sup.5 ;
- R.sup.5 denotes (C.sub.1 -C.sub.8)-alkyl which is substituted
- a) by amino-(C.sub.2 -C.sub.14)-alkylaminocarbonyl, where the alkyl radical is unsubstituted or is substituted by hydroxyl, amino, mercapto, (C.sub.1-C.sub.8)-alkoxy, phenyl or phenyl-(C.sub.1 -C.sub.4)-alkyl, and which
- b) is additionally substituted by from zero to two identical or different radicals selected from the group consisting of hydroxyl, hydroxycarbonyl, aminocarbonyl, amino, mercapto, (C.sub.1 -C.sub.8)-alkoxy, (C.sub.1 -C.sub.8)-alkoxycarbonyl, phenyl-(C.sub.1 -C.sub.3)-alkoxycarbonyl, (C.sub.3 -C.sub.8)-cycloalkyl and a radical R.sup.6 ;
- R.sup.6 denotes phenyl, phenyl-(C.sub.1 -C.sub.4)-alkyl or denotes a radical R.sup.7, where the phenyl radical is unsubstituted or is substituted by one or more identical or different radicals selected from the group consisting of (C.sub.1 -C.sub.8)-alkyl, (C.sub.1 -C.sub.8)-alkoxy, halogen, nitro and trifluoro-methyl;
- R.sup.7 denotes --NR.sup.8 R.sup.9, --OR.sup.8, --SR.sup.8, an amino acid side chain, a natural or unnatural amino acid radical, imino acid radical or dipeptide radical or an ester or amide thereof, or denotes a radical --COR.sup.7', in which R.sup.7' is defined as R.sup.7 ;
- R.sup.8 denotes hydrogen, (C.sub.2 -C.sub.8)-alkyl, phenyl-(C.sub.1 -C.sub.4)-alkyl, (C.sub.1 -C.sub.8)-alkylcarbonyl, (C.sub.1 -C.sub.8)-alkoxycarbonyl, phenylcarbonyl, phenyl-(C.sub.1 -C.sub.4)-alkylcarbonyl, or phenyl-C.sub.1 -C.sub.4)-alkoxycarbonyl;
- R.sup.9 denotes hydrogen, (C.sub.1 -C.sub.8)-alkyl, phenyl or phenyl-(C.sub.1 -C.sub.4)-alkyl;
- or their physiologically tolerable salts.
Dependencies are inferred from the claim text.